Download Docs
Export
Print

LONFUTRI

99918600 | Trademark

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed July 2, 2026
Serial No. 99918600
Examining Attorney CHIOMA N OPUTA
Class Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for use as a gene editing therapy; Pharmaceutical preparations for the treatment of hereditary angioedema; Pharmaceutical and biological preparations for treating and managing hereditary angioedema (HAE) and complications caused by hereditary angioedema (HAE); Pharmaceutical and biological preparations for use as a one-time treatment for hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency (Type 1 or Type 2); Pharmaceutical and biological preparations for use as a gene editing therapy that inactivates the KLKB1 gene and lowers plasma prekallikrein levels; Pharmaceutical and biological preparations for use as a gene editing therapy for hereditary angioedema (HAE); Pharmaceutical and biological preparations, namely, gene editing preparations for treating and managing swelling attacks; Therapeutic agents in the nature of a CRISPR/Cas9 system for treating hereditary angioedema (HAE); 005; 006; 018; 044; 046; 051; 052
LONFUTRI
Case Type Trademark
Status A non-final Office action has been sent (issued) to the applicant. This is a letter from the examining attorney requiring additional information and/or making an initial refusal. The applicant must respond to this Office action. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Last Updated: 9 hours ago
Filing Date # Docket Text